Biontech starts construction of first mrna vaccine manufacturing facility in africa

Mainz, germany and kigali, rwanda, june 23, 2022 (globe newswire) – biontech se (nasdaq: bntx, “biontech”) has reached the next milestone in the establishment of scalable mrna vaccine production in africa on its planned schedule. today, biontech welcomed its african partners for the first time on the african continent as construction works for the initial african mrna manufacturing facility began in kigali, rwanda, with a target for the first set of manufacturing biontainers to be delivered to the site by the end of 2022. the company expects to set up additional factories in senegal and south africa in close coordination with its partners in the respective countries. the initial site will become a node in a decentralized and robust african end-to-end manufacturing network. all vaccines to be manufactured in the network will be dedicated to people residing in member states of the african union.
BNTX Ratings Summary
BNTX Quant Ranking